Latest / Get Real with Jim Weiss / Disease Knows No Politics with former NIH Director Dr. Elias Zerhouni
Transcript
- 0:00Speaker 1: Hi, Jim, Hey Kate.
- 0:02Speaker 2: But an episode, Oh my gosh.
- 0:04Speaker 1: Yeah, oh jeez. You know a lot of the things
- 0:07Speaker 1: that we have now today he helped build the foundation
- 0:10Speaker 1: for in the years that he ran the NIH.
- 0:13Speaker 2: One of the measures he passed as NAH director had
- 0:15Speaker 2: to do with obesity. And you asked him what do
- 0:18Speaker 2: we know now we didn't know then? And he said
- 0:20Speaker 2: he feels he knew everything. Then it's a question of
- 0:24Speaker 2: moving it forward.
- 0:25Speaker 1: Well, what are the economics you know? And this is
- 0:27Speaker 1: the truth of it all. It's like money drives it all,
- 0:31Speaker 1: or financial interests drive it all. So I think everybody
- 0:34Speaker 1: because of you, of the way things are getting approached
- 0:37Speaker 1: and the disruption and the sort of counter mindset that
- 0:41Speaker 1: is challenging the status quo. But I think it's never
- 0:43Speaker 1: bad to challenge the status quo, which what he talked
- 0:46Speaker 1: about always doing. Yeah, and his accomplishments as an immigrant
- 0:52Speaker 1: he seems incredibly.
- 0:54Speaker 2: Proud of, certainly, And it's a rarity to talk to
- 0:57Speaker 2: somebody who worked for President Reagan, George W. Bush, President
- 1:01Speaker 2: Obama and was knighted by President Sarkozy.
- 1:04Speaker 1: That is yeah, yeah, it's quickly. I mean, I've known
- 1:06Speaker 1: him on the board of the foundation of the National
- 1:08Speaker 1: Institute of Health. And the guy always adds, like the
- 1:12Speaker 1: smartest commentary all the time. So to be in the
- 1:16Speaker 1: presence of someone so brilliant, so cool, also, you know,
- 1:20Speaker 1: easy to talk to. And I think that's what I
- 1:22Speaker 1: think people will be impressed by in this episode. Agreed, Hey, Doc,
- 1:29Speaker 1: how are you good?
- 1:30Speaker 3: Good? Hell are you? Jim?
- 1:31Speaker 1: Thanks for being here. It's a real honor to have
- 1:33Speaker 1: you here.
- 1:34Speaker 3: Thank you for having me.
- 1:35Speaker 1: All right, this summer you published this book, Disease Knows
- 1:39Speaker 1: No Politics. What a great title like so timely? Why
- 1:44Speaker 1: write the book now? What prompted you to do it?
- 1:47Speaker 3: To be honest with you, it was not like for now, Okay,
- 1:51Speaker 3: just it's one of those things that happens. I had
- 1:54Speaker 3: a good friend of mine who has badgering me for
- 1:56Speaker 3: thirteen years to write a book. So your story is special, special,
- 2:02Speaker 3: No time, I don't have time. I'm busy with lot
- 2:04Speaker 3: of things, and who wants to write a book. But
- 2:06Speaker 3: time opened up three four years ago and I said, Okay,
- 2:10Speaker 3: I'll do it. Find a way to do it effectively.
- 2:13Speaker 3: The title actually is not new. We selected this title
- 2:17Speaker 3: a while back with the publisher and advisors because it
- 2:22Speaker 3: was actually the sentence I pronounced when I was being
- 2:25Speaker 3: nominated for the job of Fedish director. If you recall
- 2:30Speaker 3: at that time there was a huge controversy about stem
- 2:32Speaker 3: cell research. Yes, and I wasn't funded and pro life,
- 2:36Speaker 3: pro choice, you know, Bush and so on and so forth,
- 2:40Speaker 3: and so there was a huge tension there. And I
- 2:42Speaker 3: agree to be the Anglish director for one reason is
- 2:45Speaker 3: that when I was at Hopkins, I was a you know,
- 2:48Speaker 3: executive ized dean. But I tried to develop the research
- 2:51Speaker 3: and we couldn't get any funding for step cell. We
- 2:53Speaker 3: had Gerhardt, who was a leader in the field, they
- 2:56Speaker 3: couldn't get money. So I got private money to create
- 2:59Speaker 3: a engineering institute. So I knew that the thing was blocked.
- 3:03Speaker 3: There was no federal money at all. And then Bush
- 3:08Speaker 3: made the decision that he said, well, if the embryo
- 3:10Speaker 3: has been destroyed, might as well use it for research,
- 3:13Speaker 3: and so he allowed the research to be funded for
- 3:16Speaker 3: the seventy eight lines that were already destroyed. He said, well,
- 3:20Speaker 3: I tow that away in the trash. I mean, no,
- 3:22Speaker 3: we should learn science and so on. That was a
- 3:24Speaker 3: great solomonic decision. He got hated by the Democrats and
- 3:27Speaker 3: hated by the Republicans because he didn't he didn't please
- 3:32Speaker 3: either one of them.
- 3:33Speaker 1: And I like that.
- 3:34Speaker 3: I thought, wow, this guy's Nice's greaty, really good. And anyway,
- 3:39Speaker 3: I met him and he told me, he said, look,
- 3:41Speaker 3: I guarantee if you get this job, I want you
- 3:44Speaker 3: to know that I will double the nice budget. You know,
- 3:47Speaker 3: I committed to that. I'm committed to them in the campaign,
- 3:49Speaker 3: and I'll do it because I believe in you guys
- 3:51Speaker 3: being number one in the world and I want to
- 3:53Speaker 3: stamp out HIV AIDS. And I said, well, Surpresident. Sure.
- 3:57Speaker 3: And then when I was in Congress, they started badgering
- 4:00Speaker 3: me about what's your position stem Cells. I said, listen,
- 4:04Speaker 3: the NIGE director has to be factual, not factual. I
- 4:07Speaker 3: tell you the science. You make the politics. I'm not
- 4:10Speaker 3: a politician, and disease knows no politics. And it was
- 4:14Speaker 3: recorded in my testimony in Congress. You'll find actually that
- 4:18Speaker 3: you know the video that has me say that, I.
- 4:20Speaker 1: Think we need to get that to go viral.
- 4:23Speaker 3: Yeah. Again, that's when the guys were, you know, looking
- 4:27Speaker 3: at the book. The title was like, well, the Life
- 4:30Speaker 3: Journey of the Nish Director, The life journey of his immigrant,
- 4:33Speaker 3: you know. And I was like, come on, guys, this
- 4:37Speaker 3: is like vanilla, you know. And then I said, what
- 4:39Speaker 3: about disease knows no politics. It's actually something that we
- 4:44Speaker 3: we should say. So to make a long story short,
- 4:48Speaker 3: that's why this title showed up. And then boom with
- 4:51Speaker 3: the Trump election, it sort of became like front end
- 4:54Speaker 3: because politics is into diseases right now, big time, much
- 4:58Speaker 3: more so than ever before.
- 5:00Speaker 1: But you work with Trump, right, No, I never wanted
- 5:03Speaker 1: you were not there for any of the Trump periods.
- 5:06Speaker 3: No. The closest I came to be asked was for
- 5:11Speaker 3: the operation Warp Speed.
- 5:13Speaker 1: That's right, that's right.
- 5:14Speaker 3: Yeah. And I had to work with Alex Azar who
- 5:18Speaker 3: was Deputy Secretary of HHS and so he knew me
- 5:21Speaker 3: and Tony foul she was at that time working with him,
- 5:25Speaker 3: and they said, well, we need to do something. So
- 5:28Speaker 3: he and I don't know how exactly, they came up
- 5:30Speaker 3: with this warp Speed idea and they called me up
- 5:33Speaker 3: and I said, look, it's a terrific idea. You should
- 5:35Speaker 3: pursue it, but you got to find money. You can't
- 5:38Speaker 3: do it on the cheap. So they came up with
- 5:41Speaker 3: the concept and then Kushner Jared Kushner really helped them
- 5:45Speaker 3: get it through the White House, and the President bought
- 5:48Speaker 3: into it. Then came to recruit somebody, and so they
- 5:51Speaker 3: came to me and I said, look, I can't really
- 5:56Speaker 3: I'm not the guy you want. I mean, I know aboutaccines,
- 6:00Speaker 3: but I didn't develop vaccines. And then this helped. If
- 6:03Speaker 3: you tak you can commit to do it before the election,
- 6:06Speaker 3: I said, I can't do that. You know, it depends
- 6:09Speaker 3: on the attack rate, how many cases there would be
- 6:11Speaker 3: over what period of time to prove that it works,
- 6:13Speaker 3: and so and I said, by the way, you should
- 6:15Speaker 3: take somebody like Massif slowly because he's really had the
- 6:19Speaker 3: vaccine and GSK his experience and so on. So then
- 6:23Speaker 3: the League came out that the White House was going
- 6:26Speaker 3: to ask me. But then when they checked the background
- 6:30Speaker 3: of what people said. I had said that the management
- 6:34Speaker 3: of the pandemic early on right is amateur hour. It's published.
- 6:41Speaker 3: He came out, if you do it, look it up.
- 6:43Speaker 3: But I was saying that about the testing, you know,
- 6:46Speaker 3: I wasn't saying that about Trunk. I was saying that
- 6:48Speaker 3: about the testing fiasco at CDC. You know, they take
- 6:52Speaker 3: the title, they don't read the text, and even though
- 6:54Speaker 3: I was a Republican administration guy, they chickened out and
- 6:59Speaker 3: things God, because I wasn't willing to do it. That's
- 7:02Speaker 3: the closest I came to working with the Trump administration
- 7:06Speaker 3: through Alexesar and Tony Fauci.
- 7:09Speaker 1: Well, see things happen the way they're supposed to work out.
- 7:12Speaker 1: I guess. So your creative science and public health should
- 7:16Speaker 1: stay independent from politics and everyone deserves equal care. Is
- 7:21Speaker 1: that something you think still achievable.
- 7:23Speaker 3: It's a challenge, you know. And simply because the science
- 7:27Speaker 3: is driven through politics, choices are being made which are
- 7:31Speaker 3: not scientific. They're political. I'm not saying that. You know,
- 7:35Speaker 3: there should be no politics in healthcare, and it's imminently political. Right,
- 7:40Speaker 3: you got to make choices, and they have to, but
- 7:43Speaker 3: the science should not be political. So you can't mix
- 7:46Speaker 3: up politics and assessing disease. So when you're saying Mr
- 7:50Speaker 3: Anda vaccines are bad, I know it. I swear to God,
- 7:53Speaker 3: I don't want to fund any of it. That's not
- 7:56Speaker 3: a scientific decision, it's the political decision that affects many,
- 8:00Speaker 3: many potential diseases. Same thing in public health. When you say, oh,
- 8:05Speaker 3: Tailan l is the cause of autism. Where did you
- 8:08Speaker 3: come up with that? But it's a political thing. It's
- 8:10Speaker 3: a political thing for a movement, and all the lawyers
- 8:13Speaker 3: are behind it to try to invade the vaccine Fund,
- 8:17Speaker 3: the vaccine compensation fund. People don't know that I've been
- 8:21Speaker 3: in this thing in the crosshair of the anti vax
- 8:24Speaker 3: folks when I was an atactor and one of them
- 8:27Speaker 3: was a good friend. He said, Oh, you don't understand.
- 8:30Speaker 3: We need to prove a link between autism and vaccines
- 8:33Speaker 3: because our kids require special care and we don't have
- 8:36Speaker 3: the means. We need to be compensated by the vaccine fund.
- 8:39Speaker 3: And then you can see what he's doing, right Kennedy
- 8:43Speaker 3: today is trying to remove the judges from the vaccine
- 8:47Speaker 3: Fund and get new judges that will be willing to
- 8:49Speaker 3: compensate folks. So it's a big billions of dollars class
- 8:54Speaker 3: action type thing where some big law firms are going
- 8:58Speaker 3: to make a lot of money. So there's eruption going
- 9:00Speaker 3: on in my view. So it's just not clear to
- 9:03Speaker 3: me that everything is really driven by science. Actually, we
- 9:07Speaker 3: were the sort of evidence free zone right now. Everybody
- 9:10Speaker 3: cherry picks what they like and then they say what
- 9:14Speaker 3: they want, and you cherry pick the committees. You cherry
- 9:17Speaker 3: pick the directors of CDC. If you don't like them,
- 9:20Speaker 3: you fire them. The same thing at FDA. Here's a
- 9:23Speaker 3: perfect storm, my friend, it's a perfect storm.
- 9:26Speaker 1: And I think you know it's been going on forever.
- 9:27Speaker 1: I remember when I was at Genantec. That's what our
- 9:30Speaker 1: Levinson preached, and all of those guys and Sue Helman,
- 9:34Speaker 1: follow the science. We'll get to the right outcome, right.
- 9:37Speaker 1: And I think they did come out and refute the
- 9:40Speaker 1: thing about tile and awe and autism, at least that
- 9:44Speaker 1: they there wasn't a causal link. I've seen a lot
- 9:46Speaker 1: of coverage, even just in the last week or so.
- 9:49Speaker 3: You know, when you talk about science, I mean data
- 9:51Speaker 3: carries the truth. You know, people say, in God, we
- 9:54Speaker 3: trust everybody else, bring data right.
- 9:57Speaker 1: All right, We're not going to solve that on this
- 9:59Speaker 1: called it. Our beliefs are shaped so much by how
- 10:02Speaker 1: we grew up. You had quite an interesting upbringing. Let's
- 10:06Speaker 1: go back a little bit in Algeria during the War
- 10:09Speaker 1: of Independence. How did your upbringing inform what you became
- 10:14Speaker 1: and what you believed?
- 10:16Speaker 3: So two things. One is the fact that you know,
- 10:19Speaker 3: when you're a child between you know, two and eleven
- 10:23Speaker 3: years old, which was my age at the time, you
- 10:26Speaker 3: see a collapse of the ecosystem, the civilization, the culture
- 10:30Speaker 3: around you into violence and you live with that and
- 10:34Speaker 3: you see the fear in your father's eyes, in your
- 10:37Speaker 3: mother's eyes that you could be a victim tomorrow. So
- 10:40Speaker 3: you have this sense that life instability needs to be
- 10:43Speaker 3: worked on and you need to be resilient about it.
- 10:46Speaker 3: So resilience for me became very important in that controlling
- 10:51Speaker 3: your fear and being resilient. That's what happens in the
- 10:54Speaker 3: period of civil war. And it's never left me. I
- 10:57Speaker 3: mean it's you know, people think it's oh, you can
- 11:00Speaker 3: get it. You know, your mind will forget it. No,
- 11:02Speaker 3: it stays with you all your life, especially if you
- 11:04Speaker 3: were a kid. But there is a silver lining to it.
- 11:07Speaker 3: So let me tell you what that is. Schools were
- 11:10Speaker 3: not open all the time. You couldn't go to the
- 11:13Speaker 3: schools when you wanted to. So my education was like
- 11:16Speaker 3: Swiss cheese. There were big gas because there were things,
- 11:19Speaker 3: you know, like plan biology, things that you learned well
- 11:22Speaker 3: that I never had. But my father was a teacher,
- 11:25Speaker 3: so he said, look, you're not going to go to school,
- 11:28Speaker 3: but you go to learn by yourself. So here are
- 11:30Speaker 3: the books. I want you to do that. And I
- 11:32Speaker 3: have brothers, so we were all like sort of a
- 11:35Speaker 3: mini schools, like at homeschooling without wanting it, that's why
- 11:38Speaker 3: we did. And I learned to learn. You see that word,
- 11:42Speaker 3: I learned to learn. That is something that doesn't leave you,
- 11:46Speaker 3: and it's a huge asset. So it created resilience, obviously
- 11:51Speaker 3: dominating your fear, which is always in the background. But
- 11:54Speaker 3: also it taught me something that I wouldn't have learned
- 11:56Speaker 3: if I had gone to regular school in the regular time.
- 12:00Speaker 1: Teams for success in life, I think generally. So how
- 12:03Speaker 1: do you and your wife pull off integrating when you
- 12:05Speaker 1: asked with a few hundred dollars in your pockets so
- 12:08Speaker 1: you could study at John's. How did that all happen?
- 12:11Speaker 3: It happened because look, when I grew up, I grew
- 12:14Speaker 3: up with math and physics. My father was teaching math
- 12:16Speaker 3: and physics. He never thought I should be a doctor.
- 12:20Speaker 3: He thought doctors are stupid, and he said, you're going
- 12:23Speaker 3: to medicine. You're your nuts. You're better than that, son.
- 12:26Speaker 3: So I said no. My wife was actually in the
- 12:30Speaker 3: medical school, and you audited it for a six month
- 12:33Speaker 3: when my university, you know, so I chose math. I
- 12:36Speaker 3: got bored to death. The people are boring their own nerds,
- 12:40Speaker 3: and I'm a different kind of guy. I like challenges.
- 12:42Speaker 3: I like to post questions. So the teachers didn't like me.
- 12:45Speaker 3: I didn't like them. I talked to her, I don't
- 12:47Speaker 3: call them mind. He said, go to medicine. Medicines for you.
- 12:49Speaker 3: I mean, you seem to be attached to people. And
- 12:53Speaker 3: I had seen the suffering, and so I went to medicine,
- 12:56Speaker 3: and guess what I found out. My father was right
- 13:00Speaker 3: that it was boring and it was road learning, and
- 13:04Speaker 3: then you had to learn and write prescription and things
- 13:07Speaker 3: that if you ask a question at the time, they said,
- 13:10Speaker 3: why are you asking you the question? I mean, listen,
- 13:12Speaker 3: we have six hundred students here. You just learn and
- 13:15Speaker 3: take your tests. And so I was going to leave.
- 13:19Speaker 3: An uncle of mine, who was a radiologist, showed me
- 13:21Speaker 3: the first cascan in the world, right by Hodsbrey Galsfield.
- 13:25Speaker 3: He said, look, this is a fantastic revolution. I said,
- 13:28Speaker 3: tell me about it, and he showed me the brand
- 13:30Speaker 3: and you could see the ventricles, and so how is
- 13:33Speaker 3: that made? And he described it for me. I still
- 13:36Speaker 3: remember he said, Oh, well, it's an X ray tube
- 13:39Speaker 3: rile around and the detector and computer that reconstructed the images.
- 13:45Speaker 3: So it's math and physics and biology. That's what I
- 13:48Speaker 3: want to do. And that's how I decided not so
- 13:52Speaker 3: much to stay in medicine, but to do research in
- 13:55Speaker 3: biomedical imaging, because I was excited about this and it
- 13:59Speaker 3: was a very big beginning of it, Jim, and no
- 14:01Speaker 3: one could teach you that except in the US, so
- 14:05Speaker 3: I had to take all the exams. And then the
- 14:06Speaker 3: dean of my medical school wrote to the denotop Kis,
- 14:09Speaker 3: who was a radiologist too, and that's how they let
- 14:12Speaker 3: me come for a short time, which became fifty years.
- 14:16Speaker 1: That's a short journey. But it's just interesting how radiology
- 14:22Speaker 1: was the root, and I think it doesn't get it's
- 14:25Speaker 1: now getting. It seems to be coming back. You know,
- 14:28Speaker 1: we're seeing a lot more radio therapeutics. It's like there
- 14:30Speaker 1: was a period of time where it was something. Now
- 14:33Speaker 1: it's become much bigger again. Talk a little bit about
- 14:37Speaker 1: the importance of radiology. I don't think we get into
- 14:40Speaker 1: it enough. But why is it so important?
- 14:43Speaker 3: Yeah, when you say radiology, you limit yourself to what
- 14:46Speaker 3: really we're talking about, which is non invasive imaging. And
- 14:49Speaker 3: you do that at the microscopic level, you know, the
- 14:52Speaker 3: molecular level or MRI or even at the astronomical level.
- 14:57Speaker 3: It's imaging. What is its the spatial localization of biological
- 15:03Speaker 3: information that you extract in a spatially temporarily resolved manner.
- 15:08Speaker 3: So look at the number of Nobel Prices that have occurred.
- 15:12Speaker 3: I mean, Betsig got a nomil price because he found
- 15:15Speaker 3: a way to image single molecules through a physical thing
- 15:20Speaker 3: that nobody really figured out before. And so when you
- 15:23Speaker 3: look at radiology, you shouldn't think radiology, you think should
- 15:26Speaker 3: the science of imaging, imaging, bioimaging in general, because the
- 15:31Speaker 3: reconstruction algorithms, the technologies, how do they change. They changed
- 15:36Speaker 3: by what they use. They use X rays, or they
- 15:38Speaker 3: use sound, or they use radio waves or MRI or
- 15:42Speaker 3: radioactivity for others. But they all common converge into one big, absolute,
- 15:48Speaker 3: major trunk of science, which is imaging. Whether it be
- 15:52Speaker 3: electron microscopy or crystallography or they're all based on the
- 15:56Speaker 3: same concepts. So radiology is just a small part of it,
- 16:00Speaker 3: right is at the forefront of medical applications. It's become
- 16:05Speaker 3: like a pillar of medical care right now. On top
- 16:09Speaker 3: of it, when you do medical imagining, you can apply AI.
- 16:13Speaker 3: It's probably the field that's the most advanced in terms
- 16:16Speaker 3: of applying AI.
- 16:18Speaker 1: And you know, I had my clearly tests, so I
- 16:20Speaker 1: know that's one of the ways the heart flow clearly tests.
- 16:24Speaker 1: That was testing claque or mimography for that matter, you know, right,
- 16:28Speaker 1: that's another one. Yeah, so you know how AI is
- 16:31Speaker 1: going to change the way we even discovered drugs. So
- 16:34Speaker 1: I think the radiology has always been a leading edge
- 16:37Speaker 1: and I was lucky to I joined it because I
- 16:39Speaker 1: was frustrated with core medicine and you know, my life
- 16:44Speaker 1: has been a little bit of that sort of opportunistic
- 16:47Speaker 1: and accidental. Well let's go to that now. Yeah, why
- 16:51Speaker 1: you're vice chair of radiology at Eastern Virginia Medical School.
- 16:54Speaker 1: You're also a consultant for the WHO and the White
- 16:58Speaker 1: House under Reagan. How did that have How did you
- 17:00Speaker 1: stumble into that or just it happens?
- 17:03Speaker 3: No, No, the Virginia thing, I had to do it
- 17:05Speaker 3: because my wife wanted to do her residency after we
- 17:09Speaker 3: had our first two children. She had a residency in
- 17:12Speaker 3: Eastern Virginia Medical School. And at the same time, by chance,
- 17:16Speaker 3: one of my teachers from Hopkins became MA chair in
- 17:19Speaker 3: Eastern Virginia, and so he said, I'll figure out a
- 17:23Speaker 3: way for you to come and we make sure your
- 17:26Speaker 3: wife gets the residency that she wanted. And I didn't
- 17:29Speaker 3: have a visa to stay, and they said, we'll figure
- 17:32Speaker 3: out your visa. So that was the reason I went there.
- 17:35Speaker 3: But he had promised me research time and the lab,
- 17:39Speaker 3: and that's when I started to do my independent research.
- 17:43Speaker 3: And I created a technology that really could differentiate cancer
- 17:48Speaker 3: from malignant legions in the lawn. And I created a
- 17:50Speaker 3: company for it. And the book says why I did
- 17:53Speaker 3: because nobody wanted to do it. The big companies didn't
- 17:55Speaker 3: want to do it because the market would have been disrupted.
- 18:01Speaker 3: But that invention was actually I taught that to my residence.
- 18:06Speaker 3: It turns out one of the residents went at the
- 18:08Speaker 3: Tesla Naval Hospital and she was in the team that
- 18:12Speaker 3: took care of the resident of the President, and he
- 18:15Speaker 3: had a nodule and they couldn't do what they couldn't
- 18:18Speaker 3: They couldn't tell what to do because he had a
- 18:20Speaker 3: long answer, and they said we need to do something,
- 18:22Speaker 3: and we operated, and she said, wait, wait, wait, I
- 18:25Speaker 3: know my professor and Virginia he developed this test and
- 18:30Speaker 3: he could tell us if it's benigna and malignant, if
- 18:32Speaker 3: we should operate or juice, wait or do nothing. That's
- 18:36Speaker 3: how I got in touch with the White House through
- 18:38Speaker 3: my resident.
- 18:39Speaker 1: So what I was.
- 18:40Speaker 3: Doing in the research I did in Virginia. So you see,
- 18:44Speaker 3: went to Virginia because my wife had a lab discovered
- 18:48Speaker 3: something that was really fascinating that had really, you know,
- 18:52Speaker 3: imagine as a solution to a lot of people who
- 18:55Speaker 3: were getting operated for nothing. A resident of mine was there.
- 18:59Speaker 3: She goes to the Navy hospital and calls me up
- 19:03Speaker 3: one day and said, we need you for a VIP.
- 19:05Speaker 3: Well it turns out to be was Reagan. So hell
- 19:08Speaker 3: a VIP.
- 19:09Speaker 1: That's kind of funny. Your wife sounds amazing without them
- 19:13Speaker 1: or nothing. As you know, I lost mine at the
- 19:15Speaker 1: end of last year to cancer. And the partnership we
- 19:19Speaker 1: had was remarkable, how we worked together, and it sounds
- 19:22Speaker 1: like you two did too.
- 19:24Speaker 3: We met when we were in high school. We're a
- 19:25Speaker 3: swimming team right. So there's a part of being in
- 19:28Speaker 3: the same team. That's one and two. We went to
- 19:32Speaker 3: the same medical school. But the other thing that binds
- 19:35Speaker 3: you and bonds, you know, the bonding is when you
- 19:39Speaker 3: come to a different country on your own. It's like
- 19:41Speaker 3: you're going to isolated island. We have no friends, no family,
- 19:46Speaker 3: no support. So who do you turn to? You turned
- 19:48Speaker 3: to your wife, she turns to you. And the luck
- 19:52Speaker 3: have it that we had beautiful children and she decided
- 19:55Speaker 3: to sacrifice her career really for mine, and I cannot
- 19:59Speaker 3: forget that. I can not ignore that. So we stayed
- 20:02Speaker 3: bunded because it was like a couple in the ocean
- 20:06Speaker 3: of America's opportunities, right, the American dream. You can't leave it,
- 20:11Speaker 3: you know, without some support, if you're an immigrant with
- 20:15Speaker 3: no real roots here.
- 20:17Speaker 1: Well, I love that. That's a great story. And I
- 20:20Speaker 1: obviously the partnership bringing out the best in each other,
- 20:23Speaker 1: all those things you know so important. Then you get
- 20:26Speaker 1: this role of a lifetime, right. You know, what were
- 20:28Speaker 1: you thinking when George Bush calls and asks you to
- 20:32Speaker 1: serve as the director of NAH I.
- 20:35Speaker 3: Thought they had made a mistake. They had the wrong number.
- 20:38Speaker 1: Why was that?
- 20:40Speaker 3: Because I never thought that it would ever be considered.
- 20:43Speaker 3: You know why. I mean, you know how they called
- 20:45Speaker 3: me when I became an int director. Who Who's this? Who? So?
- 20:52Speaker 3: So I said, well, are you sure you want to
- 20:55Speaker 3: talk to me? And they said, yeah, yeah, you have good,
- 20:59Speaker 3: good recommendations and people know you. And I had been
- 21:01Speaker 3: elected to the National Academy by then. You know, I
- 21:05Speaker 3: was like, what was it forty nine years old or
- 21:08Speaker 3: something like that, and so they looked for that. Then.
- 21:12Speaker 3: The second reason is that I had ideas that were
- 21:16Speaker 3: pretty novel for the time. And the first idea was
- 21:20Speaker 3: I call convergence, which is the conmergence of physical and
- 21:24Speaker 3: biological sciences, just like what I experienced. And when I
- 21:28Speaker 3: was at Hopkins, I recruited people from different fields in
- 21:32Speaker 3: my lab, which was a revolution because in those days
- 21:35Speaker 3: you recruit doctors, that's it. No, No, I need the physicists.
- 21:39Speaker 3: So I created the first multidisciplinary lab at Hopkins, which
- 21:43Speaker 3: became very successful, which led me to become the chair
- 21:46Speaker 3: of my department, and then right after that the executive
- 21:49Speaker 3: Izdin in charge of research, and my motto was break
- 21:53Speaker 3: disciplinary silos, break the barriers, let the teams come together.
- 21:59Speaker 3: That's how science is being done now, it's not going
- 22:02Speaker 3: to be done otherwise. Today it's like, of sure, course,
- 22:05Speaker 3: of course, But at that time it was really revolutionary.
- 22:08Speaker 3: It was even featured in science and a new unique lab.
- 22:12Speaker 3: And because of that I got noticed and I was
- 22:15Speaker 3: always saying NIH has a problem. And then publicly, even
- 22:19Speaker 3: when I was at the on the council of the
- 22:22Speaker 3: National Cancer Institute, I said, we have a structural problem.
- 22:26Speaker 3: We've created these institutes on organ's art, lung, brain, and
- 22:31Speaker 3: yet at the same time, what was created in nineteen
- 22:34Speaker 3: forty five, the fifties and so on, which was organ
- 22:37Speaker 3: based did not really reflect the molecular classification and the
- 22:42Speaker 3: molecular pathways of disease. I said, you know, look at immunology,
- 22:46Speaker 3: it's all over. Look at how we found the treatments
- 22:50Speaker 3: for HIV through research in virology with retroviruses by Harold
- 22:55Speaker 3: Varmus and all these guys. And the ACT was not
- 22:59Speaker 3: designed for each he was designed for lastic. So how
- 23:02Speaker 3: do we have these silos when nature and science is
- 23:06Speaker 3: all interpenetrating. Well, I'll tell you somehow. The president of
- 23:11Speaker 3: my university was called by the White House. Do you
- 23:13Speaker 3: know a guy that could be the unition factory, and
- 23:16Speaker 3: they said he told them Bill Brodie. He said, look,
- 23:19Speaker 3: I'm going to give you my right arm. But there
- 23:22Speaker 3: is one guy. He made the marketing for me. And
- 23:26Speaker 3: so that's how I got that call. Because the people
- 23:29Speaker 3: were giving my name and my number out of the
- 23:31Speaker 3: Natural Academy of Medicine also my university, say you should
- 23:35Speaker 3: look into that guy, and that's what started the ball rolling.
- 23:38Speaker 1: Anything that convinced you to do it, that Bush said,
- 23:41Speaker 1: or anyone said to you that made you think, okay,
- 23:45Speaker 1: it's worth taking a shot.
- 23:47Speaker 3: When they said they were committed to doubling the NIH budget,
- 23:50Speaker 3: they wouldn't back off. When they said that they wanted
- 23:54Speaker 3: to make the difference in HIV aged globally, I said, well,
- 23:57Speaker 3: these guys are serious. And when they said, I asked him.
- 24:00Speaker 3: I said, you understand that I'm an immigrant, and you
- 24:03Speaker 3: understand I'm a Muslim, and you want to appoint me
- 24:07Speaker 3: after nine to eleven And they say, yeah, it's okay.
- 24:10Speaker 3: The President only looks at your character and if you're
- 24:13Speaker 3: a citizen in good standing and you fit this what
- 24:16Speaker 3: we need, you'll be considered. I thought that was pretty
- 24:19Speaker 3: open minded, and I said, okay, but the key thing
- 24:23Speaker 3: was because I tell you, there is a reaction of wow,
- 24:27Speaker 3: my god, the White House calls me, and then you
- 24:29Speaker 3: go to fear. Wow, I might get in the front
- 24:33Speaker 3: page of the New York Times and the Washington Post
- 24:35Speaker 3: with a scandal and so on. So I, in my
- 24:38Speaker 3: due diligence, is the one guy who convinced me. You
- 24:41Speaker 3: know the last thing. It was Harold Armas and I
- 24:45Speaker 3: recount that in the book. He knew me because I
- 24:48Speaker 3: had worked on his department MSK as an advisor, and
- 24:52Speaker 3: I was on the National Cancer Institute, so I was
- 24:55Speaker 3: somewhat known. And the people at Hopkins who we are
- 24:58Speaker 3: saying good things, and he said, look, it's actually the
- 25:02Speaker 3: right thing to do. I said, look, I don't have
- 25:03Speaker 3: your pedigree. I'm not a Nobel laureate. And he said,
- 25:06Speaker 3: don't worry about that. He said, your story is a
- 25:09Speaker 3: convincing story of leadership adaptation, and you came from nowhere.
- 25:14Speaker 3: Look where you are at Hopkins, and people would love
- 25:16Speaker 3: that and that's what the institution needs. So that's how
- 25:21Speaker 3: it clicked. And that's the moment when I said, oh,
- 25:24Speaker 3: I'll take the plunge.
- 25:25Speaker 1: I mean, and look what happened. So walk us through
- 25:28Speaker 1: a few of the big achievements under your leadership and
- 25:30Speaker 1: how they laid the groundwork for today. What were some
- 25:34Speaker 1: of the big things.
- 25:35Speaker 3: I would summarize it in three number one. I was
- 25:38Speaker 3: very convinced that the peer review system was conservative, and
- 25:42Speaker 3: I created the Pioneer Award, the New Innovator Award, a
- 25:46Speaker 3: series of awards that did not have the standard peer
- 25:50Speaker 3: review process, which is a terrible thing. I mean, the
- 25:53Speaker 3: peer review process is good at preventing bad science, it's
- 25:57Speaker 3: terrible at identifying great science. Because you have these diverse
- 26:02Speaker 3: panels which are mandated, by the way, by federal law,
- 26:06Speaker 3: and you can't escape them. You got to have representation
- 26:09Speaker 3: and diversity. The north to south east, the west is
- 26:11Speaker 3: a tomato, zucchini, a carrot, you know, and they come together,
- 26:16Speaker 3: and you know what happens when you have a group
- 26:18Speaker 3: like that, You have a regression to the met Yes,
- 26:21Speaker 3: and I said, forget that. So I would say my
- 26:23Speaker 3: first contribution that I wanted was that the Pioneer Award,
- 26:27Speaker 3: which has been considered by the Academy very successful. Then
- 26:32Speaker 3: the second was what I was just telling you about
- 26:34Speaker 3: the physical sciences and biological sciences coming together with computational sciences.
- 26:40Speaker 3: I doubled the funding of non biomedical fields when I
- 26:44Speaker 3: was the director. The third one was an organizational change
- 26:49Speaker 3: where I said, you know, each institute has very strong
- 26:52Speaker 3: on constituencies and advocacy groups. You don't want to mess
- 26:55Speaker 3: up with that. But you wanted them to work better.
- 26:58Speaker 3: And so what I did the road map for medical research,
- 27:02Speaker 3: and the roadmap for medical research was based on one sentence.
- 27:06Speaker 3: I said, look me in the eye, let's talk. Tell
- 27:09Speaker 3: me what NIH should do in science today that no
- 27:14Speaker 3: instituo can do. And I let that go. And I
- 27:19Speaker 3: convened three hundred people from all walks of science and
- 27:22Speaker 3: they're okay. I mean, it was amazing. It was July August.
- 27:27Speaker 3: Only one guy turned me down because he was in
- 27:29Speaker 3: Australia with his family. And so it tells you the
- 27:32Speaker 3: power of the influence that you have, which I didn't
- 27:35Speaker 3: appreciate actually. And then they came and we had like
- 27:38Speaker 3: all these ideas about we need to do this, we
- 27:41Speaker 3: need to do that, and then we crystallized that into
- 27:43Speaker 3: a roadmap which basically said next generation of scientists, you know,
- 27:47Speaker 3: as we call the scientific teams of the future. The
- 27:51Speaker 3: molecular pathways of disease, which was the reclassification effort of
- 27:56Speaker 3: all diseases.
- 27:57Speaker 1: And that was huge. That's huge.
- 27:59Speaker 3: That was huge. And then the re engineering of the
- 28:02Speaker 3: clinical research enterprise, which was basically the Tweet team, so
- 28:08Speaker 3: leading edge science, multidisceminary science and focus on reclassification of
- 28:13Speaker 3: diseases and their understanding to a reform act. Congress has
- 28:18Speaker 3: bought it. They voted for the reform in two thousand
- 28:20Speaker 3: and six.
- 28:21Speaker 1: It sounds like it's not that long ago, but I
- 28:24Speaker 1: guess it is. The other one you got started that's
- 28:26Speaker 1: taking flight now is the focus on mental health and
- 28:29Speaker 1: behavioral disorders, right, So talk to me a little bit
- 28:32Speaker 1: about that. I mean, I would say it took a
- 28:35Speaker 1: long time for social media and the phone and all
- 28:38Speaker 1: these things that have affected the kids for that to
- 28:40Speaker 1: get better recognized. Of course, going through COVID and what
- 28:44Speaker 1: that probably caused. Do you think we're far enough there?
- 28:48Speaker 1: You know, at least we're on our way. I don't know, Oh, Jim,
- 28:51Speaker 1: that's the frontier, you know. And it's frustrating because when
- 28:55Speaker 1: I was doing the roadmap, I was very underwhelmed by
- 28:58Speaker 1: the proposals from the mental health folks and the neurology folks,
- 29:04Speaker 1: the institutes. I said, you guys are too conventional of
- 29:07Speaker 1: in We've got to do better. And so brought them together.
- 29:11Speaker 1: There were great directors that I had recruited, you know,
- 29:13Speaker 1: story lenders on INSUL and we sat down and we say,
- 29:16Speaker 1: what's missing.
- 29:18Speaker 3: What's missing? What's missing is the fact that you don't
- 29:21Speaker 3: really understand the brain at the molecular level. You think
- 29:25Speaker 3: you do. You understand him as a cellular level, you know,
- 29:28Speaker 3: with the cells, but at the molecular level during a
- 29:31Speaker 3: disease state. What happens molecularly during schizophrenia, you know, when
- 29:35Speaker 3: you have a schizophrenic delusional episode, what are the chemical
- 29:40Speaker 3: changes that occur? Well, we don't know that, you know why.
- 29:42Speaker 3: We don't know that because we think the brain is taboo,
- 29:45Speaker 3: that you can only examine the brain through its mental
- 29:48Speaker 3: health representations. What schizophrenia is an effect, is not a cause.
- 29:53Speaker 3: And so I try to shake that mentality, you know,
- 29:57Speaker 3: and say, let's be bolder, guys. And so so the
- 30:00Speaker 3: ideas started to come up, you know, like Tommy Issall
- 30:03Speaker 3: came up with his managing bipolars with a cell phone
- 30:07Speaker 3: and the brain initiative was drown the blueprint for brain,
- 30:11Speaker 3: which really started to break the barrier of this being taboo.
- 30:15Speaker 3: You know, you cannot get a CSF the tap in
- 30:19Speaker 3: clinical trials in the US, ninety percent of the time
- 30:21Speaker 3: people say no, you can biop see the brain mini
- 30:25Speaker 3: We do microbiopses and animals and so on. You can
- 30:28Speaker 3: with microdialysis you can see what happens. You don't do
- 30:31Speaker 3: that in humans. The IRBs will tell you no. And
- 30:34Speaker 3: I give them the example. The first guy who put
- 30:36Speaker 3: a catheter in the hertforcement in nineteen thirty eight got
- 30:41Speaker 3: fired by his chief and then you got the Nobound
- 30:45Speaker 3: Prize twelve years later.
- 30:47Speaker 1: Sounds like your depicts and story. These stories are so
- 30:51Speaker 1: common now. Things that are accepted as common were controversial before.
- 30:56Speaker 1: So it's been twenty five years since obesity was labeled
- 30:59Speaker 1: a health What do we know now that you wish
- 31:03Speaker 1: you'd known then?
- 31:05Speaker 3: We knew a lot then, a lot more then than
- 31:08Speaker 3: people think. And the problem is the politics of it
- 31:13Speaker 3: got in no way. This disease knows no politics. That's
- 31:16Speaker 3: an example of it. Because we looked at it and
- 31:19Speaker 3: we projected said this is a pandemic. It's going to
- 31:22Speaker 3: damage with a lot of people. The one thing we
- 31:24Speaker 3: didn't quite understand was we saw more cancers with obesity,
- 31:29Speaker 3: more diabetes. So the notion of metabolic syndrome came about
- 31:34Speaker 3: at that time, and high blood pressure and so on.
- 31:37Speaker 3: But then when we said, okay, what has changed, and
- 31:40Speaker 3: we realized that the environment had changed. So we did
- 31:43Speaker 3: this research on what we called the built environment. And
- 31:46Speaker 3: there was a researcher that said, if we built every
- 31:49Speaker 3: building in the US with no elevators until the third floor,
- 31:53Speaker 3: so you had to go in stairs, obcly we'll go
- 31:56Speaker 3: down by twenty five percent. I mean, this kind of
- 31:58Speaker 3: crazy statistics. But the biggest problem, and this is where
- 32:02Speaker 3: the current administration is going to have a little bit
- 32:04Speaker 3: of a shock when they talk about chronic diseases and obesity.
- 32:09Speaker 3: They don't realize that it's embedded in our supply chain.
- 32:13Speaker 3: For the food we could use to consume about twenty
- 32:16Speaker 3: pounds of sugar in nineteen twenty. Now it's in the
- 32:18Speaker 3: hundreds of pounds per individual. And corn syrup is probably
- 32:23Speaker 3: the number one addictive thing that drives diabetes and obesity.
- 32:29Speaker 3: If you try to change that, you get absolutely killed.
- 32:33Speaker 3: And I did. I went to Congress and I said,
- 32:35Speaker 3: we need to tax sugar. Yeah wow, you know how
- 32:38Speaker 3: that went. You know, they say, you know, if you'll
- 32:41Speaker 3: get fired before we tax sugar because we tax sugar.
- 32:45Speaker 3: They had the head of appropriation. He said, alist I
- 32:48Speaker 3: love you, but if we tax sugar, I'll get fired
- 32:51Speaker 3: at my job like this by the agricultural lobbyist. And
- 32:55Speaker 3: I don't know if you know, Kennedy promised not to
- 32:58Speaker 3: influence the agricultural policy is at his hearings because I
- 33:02Speaker 3: know the subsidies for corn syrup in agriculture sixty billion
- 33:09Speaker 3: dollars a year. Oh wow, it's bigger than the NIH budget.
- 33:13Speaker 3: And you're going to tell these guys that you want
- 33:15Speaker 3: to fix obesity by destroying their business and their subsidy
- 33:19Speaker 3: and taxing.
- 33:20Speaker 1: What they do.
- 33:21Speaker 3: I mean, it's like when the tobacco companies, we're fighting
- 33:24Speaker 3: against tobacco being a toxin. So I think there are
- 33:28Speaker 3: structural impediments that have nothing to do with about medical
- 33:31Speaker 3: research or the obesity crisis has to do with social issues,
- 33:36Speaker 3: socio economic issues and the built environment that we're built
- 33:39Speaker 3: for ourselves.
- 33:40Speaker 1: I think this stuff works itself out over time. I mean,
- 33:43Speaker 1: you know, you've got the GLP one. So there's a
- 33:46Speaker 1: lot of talk about the change of food.
- 33:48Speaker 3: Doesn't address the fundamental reasons why it's the corporate infrastructure,
- 33:53Speaker 3: agricultural structure. But I think what tends to happen over
- 33:57Speaker 3: time when you have a pandemic is that you know
- 34:00Speaker 3: will be a selection because some people will be responsive
- 34:04Speaker 3: and self correcting, like people stop smoking. You see that
- 34:07Speaker 3: the health movements. But at the end of the day,
- 34:10Speaker 3: what needs to happen is a public health intervention of
- 34:13Speaker 3: some kind. Then I think is the next step. Just
- 34:16Speaker 3: like we use statins and we really reduce the rate
- 34:19Speaker 3: of cardiovascular disease and athroscrosis to huge that right, Just
- 34:24Speaker 3: like we treated hypertension and we reduce the mortality mobility
- 34:28Speaker 3: of cardiovascular disease by two thirds, the same thing is
- 34:32Speaker 3: going to happen here. You've got to come up with
- 34:35Speaker 3: pills and things that are easier, cheaper, more widespread than
- 34:39Speaker 3: the injectable GLP one. And I think that's happening, and
- 34:43Speaker 3: I think over time we will spread the public health
- 34:46Speaker 3: intervention that is needed.
- 34:48Speaker 1: Do you think the US is under threat as a
- 34:50Speaker 1: leader in healthcare innovation and how do we change it?
- 34:53Speaker 1: What can we do.
- 34:54Speaker 3: You know, my analysis is that we're facing a commitedy
- 34:57Speaker 3: of errors, if you will, because the ecosystem of biomedical
- 35:01Speaker 3: research was created in nineteen forty five, not just biomedical,
- 35:05Speaker 3: and it was created on the compact between industry, between universities,
- 35:09Speaker 3: and between government. All three played a big role during
- 35:13Speaker 3: the war and that was sort of fast forward for
- 35:17Speaker 3: the civilian part of the world, and for seventy five years,
- 35:21Speaker 3: that's what has led to the supremacy of the United States.
- 35:25Speaker 3: So there are about seven components when you look at that,
- 35:29Speaker 3: and I'm an engineer, so I look at that in components.
- 35:33Speaker 3: Number one is federal funding because it funds is the
- 35:36Speaker 3: basic science. Number two is universities because they find the
- 35:39Speaker 3: knowledge and they trained the generation of scientists that you need.
- 35:43Speaker 3: Number three is the industry pharma. Number four is immigration
- 35:48Speaker 3: because you need the talent that you don't have. And
- 35:51Speaker 3: number five is philanthropy, which is now taxed. So look,
- 35:56Speaker 3: everything is in the challenge. Funding. They want to cut it. Universities,
- 36:00Speaker 3: they want to punish them. Pharma they have pricing issues
- 36:03Speaker 3: and we want to make pharma buckle. And then the philanthropy,
- 36:07Speaker 3: well they're politically this so we text them. Now, as
- 36:09Speaker 3: you talk to a president of the university, he's got
- 36:11Speaker 3: to pay two hundred million dollars in taxes. He said,
- 36:14Speaker 3: you know how many scholarships I could give for that?
- 36:17Speaker 3: And then venture capital, you know, is very scared right now.
- 36:21Speaker 3: There's a lot of uncertainty. It's a perfect storm. The
- 36:25Speaker 3: key thing, though, is that others are going the other way.
- 36:28Speaker 3: So today China announced a new visa called the k Visa,
- 36:32Speaker 3: where people can go in even if they don't have
- 36:34Speaker 3: a jump looking for a position, and they're attracting top
- 36:38Speaker 3: quality talent. Here we're mixing up the h one B
- 36:42Speaker 3: visa one hundred thousand dollars on people who we need
- 36:46Speaker 3: because we are four percent of the world population in
- 36:50Speaker 3: twenty five percent of the economy. You cannot train enough
- 36:54Speaker 3: people in the US for supporting that size. And every
- 36:58Speaker 3: graduate program right now is fifty percent none yous born.
- 37:02Speaker 3: The essence of what made us strong is being challenged,
- 37:06Speaker 3: and I think that's why I answered, Yeah, if cooler
- 37:09Speaker 3: heads don't prevail soon, we're going to be in deep trouble.
- 37:13Speaker 3: And at this point there's no coordination. The funding issue
- 37:16Speaker 3: for the federal government is a deficit question the universities
- 37:21Speaker 3: is a political question, it's ideological. And then the thing
- 37:24Speaker 3: about pharma, which is true, I mean the prices are
- 37:27Speaker 3: too high. It's again a populistic thing that we want
- 37:31Speaker 3: to do and the people want it done, but it
- 37:33Speaker 3: didn't understand the consequences on the total ecosystem of government.
- 37:38Speaker 3: And you know, universities in the industry.
- 37:41Speaker 1: Are you talking to the current folks about this? Are
- 37:44Speaker 1: they listening to you?
- 37:45Speaker 3: Do you think they deny that they wanted to destroy
- 37:49Speaker 3: the system? They say, oh, it's exaggerated, as you guys
- 37:53Speaker 3: are talking about guys falling and so on, and no, no, no,
- 37:56Speaker 3: we don't intend that. The president was absolutely to keep
- 37:59Speaker 3: you know, America first number one. But they're not going
- 38:03Speaker 3: on the basis of evidence. They're going on the basic opinions.
- 38:06Speaker 3: And I keep telling them, look, you know, if you
- 38:08Speaker 3: look at the number of scientists we have and engineers
- 38:11Speaker 3: two point eight million, China has four point two already
- 38:14Speaker 3: growing faster. They went from three hundred thousand students to
- 38:18Speaker 3: twelve million students, a lot of them in STEM and
- 38:22Speaker 3: they're going to pick and choose the best in the world.
- 38:24Speaker 3: And look at our own company's arm labs. I mean,
- 38:27Speaker 3: they are fifty percent foreign board. What do you want
- 38:30Speaker 3: to do and this idea that all the jobs that
- 38:34Speaker 3: are creating in America, no matter what, need to go
- 38:37Speaker 3: to American boys and American girls and no one else.
- 38:41Speaker 3: That's a very very dangerous thing when you have three
- 38:45Speaker 3: hundred and thirty million people as opposed to one point
- 38:47Speaker 3: four I mean, Jim, let's pick the smartest person, you know,
- 38:51Speaker 3: is it a one in a million person? Probably?
- 38:54Speaker 1: This.
- 38:55Speaker 3: That means that in the US, if the one in
- 38:57Speaker 3: a million talent, the Einstein of the world, you have
- 39:01Speaker 3: three hundred of them, three hundred and thirty of them.
- 39:03Speaker 3: China with one point four billion has fourteen hundred of them.
- 39:06Speaker 3: India has the same number. So look at the belt,
- 39:10Speaker 3: it's not there. We need to get that done.
- 39:12Speaker 1: It'll let some of those guys in just a middle FNIH,
- 39:15Speaker 1: because we both serve on the board. Do you think
- 39:18Speaker 1: an organization like that can help bridge some of these gaps?
- 39:22Speaker 3: Well, you know, FNIH was designed by Congress to help
- 39:26Speaker 3: because Congress realized that there were cultural frictions between the
- 39:32Speaker 3: government and IH and the industry because there was a
- 39:35Speaker 3: government organization yet at the same time and I was
- 39:39Speaker 3: the driver of innovation. So how do you get industry
- 39:42Speaker 3: in NIH at the same table. And you notice that
- 39:45Speaker 3: because of that, the Congress created this and created a
- 39:49Speaker 3: sort of a safe harbor environment that would be transparently
- 39:53Speaker 3: managing the relationships without industry getting into the NIH business.
- 39:58Speaker 3: Because what everybody's afraid of is that you get industry
- 40:02Speaker 3: or special interest driving the scientific agenda. So I say,
- 40:08Speaker 3: these knows no politics. And I should say also the
- 40:12Speaker 3: profits should not know disease, right and the opposite. And
- 40:16Speaker 3: so that's the reason why FNI is so important. There
- 40:19Speaker 3: is one for the FDA as well. FDA is even
- 40:22Speaker 3: really more difficult because people are accusing and even Kennedy
- 40:26Speaker 3: the sector. Kennedy accuses the FDA to be the control
- 40:29Speaker 3: of industry because they get the user fees, you know
- 40:33Speaker 3: when you think that way. And there is oil and
- 40:36Speaker 3: water when it comes to government and private industry, as
- 40:39Speaker 3: you well know across all government, you know, whether it
- 40:42Speaker 3: being military or health. So you've got to have these
- 40:46Speaker 3: buffer institutions like FNIH.
- 40:50Speaker 1: Agreed, So thanks, you were messed not to cover it.
- 40:53Speaker 1: Given what we do there. Do you stay in touch
- 40:56Speaker 1: with Bush and Obama? Do you talk about these things.
- 41:00Speaker 3: Not really no, no, no, no, no. They they're very
- 41:03Speaker 3: cagey if by saying anything, talking about anything, you know,
- 41:06Speaker 3: and yeah, they're very conscious of the weight of their words.
- 41:10Speaker 3: I talk about the fact that healthcare in each reform,
- 41:14Speaker 3: and I wrote the chapter there that I think is controversial,
- 41:18Speaker 3: which I like, talking about ways of approaching the health
- 41:22Speaker 3: care and disaster. We're living.
- 41:25Speaker 1: Well, we're in the middle of it, proving again there's
- 41:27Speaker 1: nothing more important than your house exactly, which is what
- 41:30Speaker 1: we're all about. So look, I just wanted to do
- 41:33Speaker 1: this and bring it full circle before we ask a
- 41:35Speaker 1: couple of fun questions. In two thousand and eight, President
- 41:38Speaker 1: Sarkozy named you a Knight of the French Legion of
- 41:43Speaker 1: out Here. A knight. I don't know what they do
- 41:45Speaker 1: in France. It's how did they say, Sir Offier? What
- 41:50Speaker 1: did that mean? As an Algerian who experienced the flight
- 41:54Speaker 1: for freedom from France, I mean, what did that mean
- 41:56Speaker 1: to you?
- 41:57Speaker 3: It was amazing. It was almost like cognitive dissonance, you know.
- 42:00Speaker 3: And I did it because I really worked on issues
- 42:03Speaker 3: that hadn't been resolved. And then when I told my mother,
- 42:05Speaker 3: I said, oh, you're going to get this legion doneur
- 42:09Speaker 3: and she said, don't take it, turn it down. I said,
- 42:12Speaker 3: what do you mean now, She said, yeah, turn it down.
- 42:15Speaker 3: Because she was an anti French. She wanted the freedom
- 42:18Speaker 3: in it. And I said why do you say that.
- 42:20Speaker 3: She said, well, you know, the people who got the
- 42:22Speaker 3: legions on her in my time were all traders, they
- 42:25Speaker 3: all collaborators, They collaborated with the colonialists. And I said, mom,
- 42:29Speaker 3: it's a different time, it's a completely different story. And
- 42:33Speaker 3: she said no, no, no, And I said, you know, they
- 42:36Speaker 3: never gave it to an Algeria after the independence, you know,
- 42:39Speaker 3: and oh really, And she eventually understood why it was
- 42:44Speaker 3: important to be recognized by the former colonial power as
- 42:49Speaker 3: somebody who really renders services to friends in the US.
- 42:52Speaker 3: Because I'm a foreigner, I'm not French. So to get
- 42:56Speaker 3: the legions on her, you know, the list of Americans
- 42:58Speaker 3: who got the legions on her, and it's very very
- 43:01Speaker 3: high level, I mean Eisenhower on pattern, and it's not
- 43:04Speaker 3: a run of the middle list.
- 43:06Speaker 1: Oh, it's a big deal.
- 43:07Speaker 3: And then she met him. You know, we were Sarkozzi
- 43:10Speaker 3: in the Za, and so they talked to me about,
- 43:13Speaker 3: you know, being from the United States, and so on.
- 43:15Speaker 3: So she came to him. She said, listen, mister president,
- 43:17Speaker 3: you got to know he's Algerian. Eh, he's Algerian, I said, Mom.
- 43:24Speaker 3: He said, no, no, I want him to know. And
- 43:26Speaker 3: he said, I know, Madam, I know, I know. He's
- 43:28Speaker 3: a degree. And so we ended up, you know, having
- 43:31Speaker 3: a good moment. That's amazing, got a great story.
- 43:34Speaker 1: I love that. Moms are everything. Right.
- 43:36Speaker 3: He came to my hearing. You know, my mother she came.
- 43:40Speaker 3: She was here and she came to the hearing with
- 43:43Speaker 3: Ted Kennedy and Ted Kennedy looked to say, who is this.
- 43:47Speaker 3: This is my mother. That's my mother here.
- 43:50Speaker 1: Really, that's cool.
- 43:52Speaker 3: I'm glad you brought your mother. You know. Mothers are important.
- 43:55Speaker 3: He was thinking about his own mother, you know, and he.
- 43:58Speaker 1: Was kidding, Wow, that's incredible. That's great. Yeah, mothers really
- 44:04Speaker 1: drive it all. Two questions I always ask before we
- 44:07Speaker 1: take off. It's been I could talk way longer, you know.
- 44:10Speaker 1: I always like to ask, what is your dream vacation. Ah,
- 44:14Speaker 1: that's a great question. Add the swimming vacation, snorkeling, scuba
- 44:22Speaker 1: diving in the Mediterranean, or somewhere nice where I can
- 44:26Speaker 1: wake up swim a mile and a half two miles
- 44:29Speaker 1: because I'm a swimmer, have a great breakfast, then go
- 44:33Speaker 1: and start spearfishing. Cool. I didn't know you did that.
- 44:37Speaker 1: That's interesting, all right.
- 44:39Speaker 3: And that's because my brain is imprinted by the sea,
- 44:42Speaker 3: because I grew up by the sea, and so that,
- 44:45Speaker 3: to me is always my definition of a great vacation.
- 44:48Speaker 3: It's cool to be like a fish in the water.
- 44:51Speaker 1: And it reveals so much about people. Yeah, this is
- 44:53Speaker 1: another one that does that. If you're being sent to
- 44:57Speaker 1: a desert island and you can only take one hour
- 45:00Speaker 1: album with you, what would the album be?
- 45:02Speaker 3: Ooh, this is a great question too. I'll tell you what.
- 45:06Speaker 3: My favorite piece of music is a twenty fifth symphony
- 45:09Speaker 3: by Mozart. That's one, but it's not the only one.
- 45:12Speaker 3: Is that co equals too because of Algerian music too
- 45:15Speaker 3: is in my blood too. And I like to plead
- 45:17Speaker 3: the luth myself.
- 45:19Speaker 1: Oh wow, and you could probably make a loot on
- 45:21Speaker 1: the island, so yeah, that could possibly happen.
- 45:26Speaker 3: You sound very good.
- 45:27Speaker 1: I'm excited to get this out there. Let's keep at it.
- 45:31Speaker 1: You're just challenging people to be better. Simple enough.
- 45:35Speaker 3: Anticipatory complaints is look good?
- 45:37Speaker 1: That's right? All right? Hey everyone, thanks for joining me
- 45:43Speaker 1: on the Get Real podcast. You know, I hope you
- 45:45Speaker 1: feel a little healthier hanging out with me. You know,
- 45:48Speaker 1: it's going to be a lot of fun passing this
- 45:51Speaker 1: along the others. Please subscribe below, Please share. I'm excited
- 45:55Speaker 1: not just to talk about healthcare, but a lot of
- 45:58Speaker 1: other fun topics. It's about making healthy. Talk about healthcare
- 46:03Speaker 1: is not a lecture.
- 46:05Speaker 3: This is supposed to be fun.
- 46:06Speaker 1: And look forward to spending more time with you in
- 46:09Speaker 1: the future.